Adipose-derived regenerative cells: Completed Phase IIb enrollment

Cytori completed enrollment of about 94 patients in the double-blind, placebo-controlled, U.S. Phase IIb ACT-OA trial evaluating 2 dose levels of intra-articular injections of ECCO-50. ...